NovaBridge Biosciences (0VY.F)
NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States.
1.40+0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-50.0%
The outlook
NovaBridge Biosciences currently reads as bearish based on below its 50- & 200-day averages, 3% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range3% of the way from its 52-week low to high
Market cap
$161.9M
52-wk high
5.60
52-wk low
1.25
50-day avg
1.50
200-day avg
2.52
Trailing P/E
—